Targeted Therapies for Epstein-Barr Virus-Associated Lymphomas

Targeted Therapies for Epstein-Barr Virus-Associated Lymphomas

The Epstein-Barr virus (EBV) is the first human tumor virus identified that can transform quiescent B lymphocytes into lymphoblastoid cell lines (LCLs) in vitro. EBV can establish asymptomatic life-long persistence and is associated with multiple human malignancies, including non-Hodgkin lymphoma an...

Full description

Bibliographic Details
Main Authors: Yonggang Pei, Josiah H. Y. Wong, Erle S. Robertson
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Cancers
Subjects:
targeted therapies
Epstein-Barr virus
lymphomas
Online Access:https://www.mdpi.com/2072-6694/12/9/2565

Similar Items

Similar Items